27. Which of the following information would be appropriate to include when dispensing cyclophosphamide 50 mg capsules?

Answer: D

Explanation:

Warning: Do not use if you are pregnant, plan to become pregnant or while breastfeeding

It is crucial to inform patients that cyclophosphamide should not be used during pregnancy, while planning to become pregnant, or while breastfeeding due to its potential teratogenic effects and risks to the fetus or infant.

A) Keep refrigerated

Cyclophosphamide does not require refrigeration for storage. This option is incorrect as it does not pertain to the appropriate handling or safety information needed for the medication.

B) May cause drowsiness

While some medications can cause drowsiness, cyclophosphamide is not primarily known for this side effect. Therefore, this option is not the most relevant information to include when dispensing this medication.

C) You should avoid prolonged or excessive exposure to direct and/or artificial sunlight while taking this medication

Although some medications may increase photosensitivity, this specific warning is not primarily associated with cyclophosphamide. Hence, this information is less pertinent compared to the critical pregnancy-related warning.

D) Warning: Do not use if you are pregnant, plan to become pregnant or while breastfeeding

This warning is essential because cyclophosphamide can cause severe birth defects if taken during pregnancy and can also affect breastfeeding. This makes it the most appropriate and necessary information to convey when dispensing this medication.

Conclusion

The warning regarding pregnancy and breastfeeding is vital for patient safety when dispensing cyclophosphamide, making option D the only appropriate choice. The other options either do not apply to cyclophosphamide or lack relevance to the critical safety information required for patients.